000			03529cam a2200409 i 4500
001			rnd000000000071763
003			RAND
005			20200811100902.0
008			030804s2003 cau b 000 0 eng d
010			_a 2003008549
020			_a0833033646 (pbk.)
027			_aRAND/MR-1546-STPI
035			_a(Sirsi) a437726
037			_c$24.00 _fpaperback
040			_aCstmoR _cCstmoR
050	0	0	_aQH332 _b.E36 2003
100	1		_aEiseman, Elisa. _eauthor.
245	1	4	_aThe National Bioethics Advisory Commission : _bcontributing to public policy / _cElisa Eiseman.
264		1	_aSanta Monica, CA : _bRAND, _c2003.
300			_axxviii, 172 pages ; _c23 cm
336			_atext _btxt _2rdacontent
337			_acomputer _bc _2rdamedia
337			_aunmediated _bn _2rdamedia
338			_aonline resource _bcr _2rdacarrier
338			_avolume _bnc _2rdacarrier
500			_a"Science and Technology Policy Institute."
504			_aIncludes bibliographical references (p. 145-172).
505	0		_aIntroduction -- NBAC in the Public Eye -- Response to the Cloning Human Beings Report -- Response to the Research Involving Persons with Mental Disorders That May Affect Decisionmaking Capacity Report -- Response to the Research Involving Human Biological Materials: Ethical Issues and Policy Guidance Report -- Response to the Ethical Issues in Human Stem Cell Research Report -- Response to the Ethical and Policy Issues in International Research: Clinical Trials in Developing Countries Report -- Response to the Ethical and Policy Issues in Research Involving Human Participants Report -- Summary -- Appendix: Data Collection Methods.
520			_aThe National Bioethics Advisory Commission (NBAC) was established by executive order in 1995 to advise the National Science and Technology Council and other government entities on bioethical issues arising from research on human biology and human behavior. During the commission's five-year tenure, it submitted six major reports to the White House that contained 120 recommendations on several complex bioethical issues, including the cloning of human beings, research involving persons with mental disorders that may affect decisionmaking capacity, research with human biological materials, embryonic stem cell research, U.S.-sponsored clinical trials in developing countries, and protection of human research participants. This RAND study was conducted to assess NBAC's contribution to the policymaking process as it relates to these issues. The author provides a detailed account of the responses to each of NBAC's six reports from the president, Congress, government, societies and foundations, other countries, and international organizations. Although no legislation has been passed based on NBAC's recommendations, agencies responsible for a major portion of federally funded research involving human participants-particularly the National Institutes of Health-have adopted several of NBAC's recommendations and issued research guidelines based on those recommendations.
530			_aAlso available on the internet via WWW in PDF format.
610	1	0	_aUnited States. _bNational Bioethics Advisory Commission.
650		0	_aBioethics _xGovernment policy _zUnited States.
650		0	_aMedical ethics _xGovernment policy _zUnited States.
710	2		_aScience and Technology Policy Institute (Rand Corporation)
710	2		_aRand Corporation.
710	1		_aUnited States. _bNational Bioethics Advisory Commission.
856	4	1	_yOnline Access _uhttp://www.rand.org/publications/MR/MR1546/
999			_c598999 _d598999